Longfor Gr Hldgsの空売り状況は、投資家がLongfor Gr Hldgsの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Longfor Gr Hldgs (OTC:LGFRY) 株価情報, 空売り情報

Longfor Group Holdings, or Longfor, is a non-state-owned real estate developer in China with contracted sales value placing it among the top 10 of all China's developers. The company focuses on developing high quality residential projects, as well as operating shopping malls and rental apartments in China's wealthier cities. Property development represents the majority of Longfor's revenue and gross profit, while income from commercial properties, property management and project management services have been growing fast. As at end-2023, Wu Yajun remained the largest shareholder with an over 43% equity interest, while her ex-husband Cai Kui has a 23% stake.

LONGFOR GRP HLD UNSP/ADR by Longfor Group Holdings Ltd.

Longfor Group Holdings Ltd

In today's rapidly changing and highly competitive business world, it is imperative for investors and industry observers to carefully assess companies before making investment choices. In this article, we will undertake a comprehensive industry comparison, evaluating NVIDIA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) vis-à-vis its key competitors in the Semiconductors &amp; Semiconductor Equipment industry. Through a detailed analysis of important financial indicators, market standing, and growth potential, our goal is to provide valuable insights and highlight company's performance in the industry.
<h3>NVIDIA Background</h3>
Nvidia is a leading developer of graphics processing units. Traditionally, GPUs were used to enhance the experience on computing platforms, most notably in gaming applications on PCs. GPU use cases have since emerged as important semiconductors used in artificial intelligence. Nvidia not only offers AI GPUs, but also a software platform, Cuda, used for AI model development and training. Nvidia is also expanding its data center networking solutions, helping to tie GPUs together to handle complex workloads.
<table>
<thead>
<tr>
<th>Company</th>
<th>P/E</th>
<th>P/B</th>
<th>P/S</th>
<th>ROE</th>
<th>EBITDA (in billions)</th>
<th>Gross Profit (in billions)</th>
<th>Revenue Growth</th>
</tr>
</thead>
<tbody>
<tr>
<td>NVIDIA Corp</td>
<td>52.73</td>
<td>49.64</td>
<td>29.32</td>
<td>31.13%</td>
<td>$22.86</td>
<td>$26.16</td>
<td>93.61%</td>
</tr>
<tr>
<td>Broadcom Inc</td>
<td>182.20</td>
<td>16.28</td>
<td>21.77</td>
<td>6.49%</td>
<td>$7.29</td>
<td>$9.0</td>
<td>51.2%</td>
</tr>
<tr>
<td>Taiwan Semiconductor Manufacturing Co Ltd</td>
<td>30.21</td>
<td>8.26</td>
<td>12.25</td>
<td>9.05%</td>
<td>$596.09</td>
<td>$512.38</td>
<td>38.84%</td>
</tr>
<tr>
<td>Qualcomm Inc</td>
<td>18.49</td>
<td>7.05</td>
<td>4.75</td>
<td>11.46%</td>
<td>$3.21</td>
<td>$5.78</td>
<td>18.69%</td>
</tr>
<tr>
<td>Advanced Micro Devices Inc</td>
<td>110.48</td>
<td>3.11</td>
<td>7.01</td>
<td>1.36%</td>
<td>$1.55</td>
<td>$3.42</td>
<td>17.57%</td>
</tr>
<tr>
<td>ARM Holdings PLC</td>
<td>211.63</td>
<td>26.41</td>
<td>46.20</td>
<td>1.83%</td>
<td>$0.11</td>
<td>$0.81</td>
<td>4.71%</td>
</tr>
<tr>
<td>Texas Instruments Inc</td>
<td>34.67</td>
<td>9.73</td>
<td>10.59</td>
<td>7.05%</td>
<td>$2.09</td>
<td>$2.47</td>
<td>-3.47%</td>
</tr>
<tr>
<td>Micron Technology Inc</td>
<td>27.49</td>
<td>2.28</td>
<td>3.70</td>
<td>4.07%</td>
<td>$4.3</td>
<td>$3.35</td>
<td>84.28%</td>
</tr>
<tr>
<td>Analog Devices Inc</td>
<td>62.46</td>
<td>2.89</td>
<td>10.84</td>
<td>1.36%</td>
<td>$1.12</td>
<td>$1.42</td>
<td>-10.06%</td>
</tr>
<tr>
<td>Monolithic Power Systems Inc</td>
<td>19.28</td>
<td>10.72</td>
<td>15.61</td>
<td>6.35%</td>
<td>$0.17</td>
<td>$0.34</td>
<td>30.59%</td>
</tr>
<tr>
<td>Microchip Technology Inc</td>
<td>91.32</td>
<td>4.64</td>
<td>5.94</td>
<td>1.24%</td>
<td>$0.34</td>
<td>$0.67</td>
<td>-48.37%</td>
</tr>
<tr>
<td>ASE Technology Holding Co Ltd</td>
<td>20.70</td>
<td>2.37</td>
<td>1.25</td>
<td>3.16%</td>
<td>$28.59</td>
<td>$26.43</td>
<td>3.85%</td>
</tr>
<tr>
<td>STMicroelectronics NV</td>
<td>13.57</td>
<td>1.16</td>
<td>1.59</td>
<td>1.95%</td>
<td>$0.74</td>
<td>$1.23</td>
<td>2.15%</td>
</tr>
<tr>
<td>ON Semiconductor Corp</td>
<td>12.96</td>
<td>2.25</td>
<td>2.87</td>
<td>4.75%</td>
<td>$0.63</td>
<td>$0.8</td>
<td>-19.21%</td>
</tr>
<tr>
<td>First Solar Inc</td>
<td>14.03</td>
<td>2.30</td>
<td>4.55</td>
<td>4.22%</td>
<td>$0.45</td>
<td>$0.45</td>
<td>10.81%</td>
</tr>
<tr>
<td>United Microelectronics Corp</td>
<td>9.75</td>
<td>1.37</td>
<td>2.19</td>
<td>4.0%</td>
<td>$29.73</td>
<td>$20.43</td>
<td>5.99%</td>
</tr>
<tr>
<td>Skyworks Solutions Inc</td>
<td>19.89</td>
<td>1.62</td>
<td>2.58</td>
<td>0.95%</td>
<td>$0.18</td>
<td>$0.43</td>
<td>-15.9%</td>
</tr>
<tr>
<td>Lattice Semiconductor Corp</td>
<td>123.80</td>
<td>10.57</td>
<td>14.79</td>
<td>1.03%</td>
<td>$0.03</td>
<td>$0.09</td>
<td>-33.87%</td>
</tr>
<tr>
<td>Qorvo Inc</td>
<td>275.93</td>
<td>2.13</td>
<td>1.96</td>
<td>1.22%</td>
<td>$0.14</td>
<td>$0.39</td>
<td>-14.67%</td>
</tr>
<tr>
<td>Rambus Inc</td>
<td>40.71</td>
<td>6.39</td>
<td>13.16</td>
<td>5.76%</td>
<td>$0.07</td>
<td>$0.12</td>
<td>10.71%</td>
</tr>
<tr>
<td>Average</td>
<td>69.45</td>
<td>6.4</td>
<td>9.66</td>
<td>4.07%</td>
<td>$35.62</td>
<td>$31.05</td>
<td>7.04%</td>
</tr>
</tbody>
</table>
<style>
 table {
 width: 100%;
 border-collapse: collapse;
 font-family: Arial, sans-serif;
 font-size: 14px;
 }

 th, td {
 padding: 8px;
 text-align: left;
 }

 th {
 background-color: #293a5a;
 color: #fff;
 text-align: left;
 }

 tr:nth-child(even) {
 background-color: #f2f4f8;
 }

 tr:hover {
 background-color: #e1e4ea;
 }

 td:nth-child(3), td:nth-child(5) {
 text-align: left;
 }

 .dividend-amount {
 font-weight: bold;
 color: #0d6efd;
 }

 .dividend-frequency {
 font-size: 12px;
 color: #6c757d;
 }
 </style>After a detailed analysis of NVIDIA, the following trends become apparent: 
<ul>
<li>
With a Price to Earnings ratio of 52.73, which is 0.76x less than the industry average, the stock shows potential for growth at a reasonable price, making it an interesting consideration for market participants.
</li>
<li>
The elevated Price to Book ratio of 49.64 relative to the industry average by 7.76x suggests company might be overvalued based on its book value.
</li>
<li>
The Price to Sales ratio of 29.32, which is 3.04x the industry average, suggests the stock could potentially be overvalued in relation to its sales performance compared to its peers.
</li>
<li>
The Return on Equity (ROE) of 31.13% is 27.06% above the industry average, highlighting efficient use of equity to generate profits.
</li>
<li>
With lower Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) of $22.86 Billion, which is 0.64x below the industry average, the company may face lower profitability or financial challenges.
</li>
<li>
The gross profit of $26.16 Billion is 0.84x below that of its industry, suggesting potential lower revenue after accounting for production costs.
</li>
<li>
The company is experiencing remarkable revenue growth, with a rate of 93.61%, outperforming the industry average of 7.04%.
</li>
</ul>
<h3>Debt To Equity Ratio</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739286022_0.png" alt="debt to equity" />
The debt-to-equity (D/E) ratio helps evaluate the capital structure and financial leverage of a company.
Considering the debt-to-equity ratio in industry comparisons allows for a concise evaluation of a company's financial health and risk profile, aiding in informed decision-making.
By considering the Debt-to-Equity ratio, NVIDIA can be compared to its top 4 peers, leading to the following observations:
<ul>
<li>
NVIDIA has a stronger financial position compared to its top 4 peers, as evidenced by its lower debt-to-equity ratio of 0.16.
</li>
<li>
This suggests that the company has a more favorable balance between debt and equity, which can be perceived as a positive indicator by investors.
</li>
</ul>
<h3>Key Takeaways</h3>
For NVIDIA, the PE ratio is low compared to peers, indicating potential undervaluation. The high PB and PS ratios suggest strong market sentiment and revenue multiples. The high ROE reflects efficient use of shareholder equity, while low EBITDA and gross profit may indicate operational challenges. The high revenue growth signifies strong top-line performance relative to industry peers in the Semiconductors &amp; Semiconductor Equipment sector.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Markets

Trading Ideas

NVDA

Competitor Analysis: Evaluating NVIDIA And Competitors In Semiconductors &amp; Semiconductor Equipment Industry

Shaquille O'Neal has <a href="https://www.benzinga.com/markets/24/07/39915962/shaquille-oneal-began-building-his-estimated-500-million-portfolio-by-investing-in-this-tech-titan-w">made more money off the court</a> than he did playing in the NBA, but that didn't happen by accident. In a 2015 <a href="https://www.youtube.com/watch?v=Mza5tTgh9hA">interview</a> with Graham Bensinger, Shaq shared how his early days with money were filled with mistakes—until he met one financial advisor who changed everything.
<h2 class="wp-block-heading">Blowing $1 Million in a Day</h2>
When Shaq got his first major endorsement check—a cool $1 million—he thought he had it all figured out. But he quickly learned that wasn't the case.
"I go and buy a $150,000 car. No negotiations. I don't know nothing about negotiations," Shaq admitted. "So I go and get a black Mercedes because that's what I always wanted."
Don't Miss:
<ul>
<li><a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a></li>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a></li>
</ul>
Then his father wanted one. Then his mother. He wrote the checks without a second thought. By the time he covered jewelry, suits for the NBA draft, and a high-end sound system, the money was gone.
A few days later, he got a call from his bank manager. "You know how to read bank statements?" the man asked. "Yeah, I learned in school," Shaq replied. But as he read through it, reality hit him—he was already $80,000 in the hole.
<h2 class="wp-block-heading">Finding the Right Advisor</h2>
The bank manager warned him: "I know you got more money coming in, but I don't want you to be like all these other athletes." Shaq had heard that phrase before. He didn't want to be another broke superstar. That's when he decided to get serious about his finances.
Trending: It&#8217;s no wonder Jeff Bezos holds over $250 million in art — <a href="https://www.benzinga.com/money/masterworks">this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%. Here&#8217;s how everyday investors are getting started.</a>
He met with several financial advisors, but most made promises that seemed too good to be true. "A lot of guys came in, telling me, ‘You give me your $40 million, I'll turn it into $200 million by the time you're 23.' I was like, ‘I don't like this guy.'"
Then he met one man who stood out.
"I met one little small, beautiful Jewish man," Shaq said. "He told me, ‘I'm into savings bonds. We're going to start a subchapter S corporation for your family, so all the stuff you're doing, you can write it off.'"
That advisor was Lester Knispel, and he has been with Shaq ever since. Unlike the flashy money managers who promised the world, Knispel focused on financial security and long-term planning.
See Also: <a href="https://www.benzinga.com/money/mark-cubans-advice-for-lotto-winners">Many are surprised by Mark Cuban's advice for lotto winners: Cash or annuity?</a>
<h2 class="wp-block-heading">A Wake-Up Call from Knispel</h2>
Even with a solid financial advisor, Shaq still had some learning to do. He recalls a moment when he and <a href="https://www.benzinga.com/real-estate/25/01/43242795/mike-tyson-splurges-13-million-on-florida-mansion-after-jake-paul-defeat">Mike Tyson</a> were at a Rolls-Royce dealership. Tyson bought three. Shaq, refusing to be outdone, <a href="https://www.benzinga.com/news/25/01/43397569/shaq-once-blew-600000-on-two-rolls-royces-because-mike-tyson-bought-three-and-he-didnt-want-to-be-outdone-by-him">bought two</a>.
That's when Knispel called him. "Hey, gotta stop this," he said. From that moment on, Shaq knew he had to be more responsible. He took financial planning seriously and built a portfolio of businesses, real estate, and endorsements that continue to pay him today.
<h2 class="wp-block-heading">More Than Just an Advisor</h2>
Shaq doesn't just see Knispel as a financial manager—he sees him as family. "He's like a father to me," Shaq said. "He's been good to me. It was the right choice to make." Thanks to that choice, Shaq has turned his NBA fortune into a <a href="https://www.benzinga.com/news/24/09/40931123/shaquille-oneals-estimated-500m-portfolio-includes-a-big-bet-on-google-but-big-shamrock-made-a-criti">financial empire</a>, proving that even a million-dollar mistake can turn into a lifelong lesson.
Read Next:
<ul>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
<li>The secret weapon in billionaire investor portfolios that you almost certainly don't own yet. <a href="https://www.benzinga.com/money/masterworks">See which asset class has outpaced the S&amp;P 500 (1995-2024) – and with near-zero correlation.</a></li>
</ul>

'Hey, Gotta Stop This'—Shaq Says He Didn't Trust Financial Advisors Until He Met This One Man Who Became Like A Father To Him

An official report on February 10, 2025 reveals Representative Victoria Spartz's recent purchase of Simon Property Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPG#NYSE">SPG</a>) stock, valued between $15,001 and $50,000. The transaction took place on February 10, 2025, as per the February filing.
At this time, Simon Property Group shares are trading up 0.45% at $181.37.
To keep an eye on Victoria Spartz's trades and other government stock activity, check out our <a href="https://www.benzinga.com/gov-trades/members/victoria-spartz">real-time tracking tool</a>!
<h3>Why Congressional Transactions Matter</h3>
A congressional transaction is when any representative or senator either buys or sells an individual stock.
Anyone working in Congress must file a Periodic Transaction Report to inform the public of their recent transaction within 30 days of being notified of the transaction and within 45 days of the transaction date.
In April 2012, Former President Barack Obama signed the STOCK Act into law. The act prohibits members of Congress from using private information given to them by their position for personal gain such as buying or selling a stock. The act also expanded disclosure requirements for members of Congress by requiring them to file a monthly disclosure.
<h3>Why Congressional Transactions Matter</h3>
Congressional transactions shouldn't be the primary reason for an investing decision, but they can be an important factor for an investor to consider.
When a senator or representative makes a new purchase, it could be an indication they expect the stock to rise.
A sale, on the other hand, can be made for a variety of reasons, and may not necessarily mean the seller thinks the stock will go down.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Government

Politics

General

Recent Filing Shows That Rep. Victoria Spartz Bought Over $15K Worth of Simon Property Group Stock

In today's fast-paced and competitive business landscape, it is essential for investors and industry enthusiasts to thoroughly analyze companies before making investment decisions. In this article, we will conduct a comprehensive industry comparison, evaluating KKR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KKR#NYSE">KKR</a>) against its key competitors in the Capital Markets industry. By examining key financial metrics, market position, and growth prospects, we aim to provide valuable insights for investors and shed light on company's performance within the industry.
<h3>KKR Background</h3>
KKR is one of the world's largest alternative asset managers, with $624.4 billion in total managed assets, including $505.7 billion in fee-earning AUM, at the end of September 2024. The company has two core segments: asset management (which includes private markets—private equity, credit, infrastructure, energy, and real estate—and public markets—primarily credit and hedge/investment fund platforms) and insurance (following the firm's initial investment in, and then ultimate purchase of, Global Atlantic Financial Group, which is engaged in retirement/annuity and life insurance lines as well as reinsurance).
<table>
<thead>
<tr>
<th>Company</th>
<th>P/E</th>
<th>P/B</th>
<th>P/S</th>
<th>ROE</th>
<th>EBITDA (in billions)</th>
<th>Gross Profit (in billions)</th>
<th>Revenue Growth</th>
</tr>
</thead>
<tbody>
<tr>
<td>KKR &amp; Co Inc</td>
<td>45.10</td>
<td>5.46</td>
<td>6.42</td>
<td>2.62%</td>
<td>$2.45</td>
<td>$0.89</td>
<td>44.56%</td>
</tr>
<tr>
<td>Brookfield Corp</td>
<td>129.13</td>
<td>2.11</td>
<td>1.01</td>
<td>0.05%</td>
<td>$8.4</td>
<td>$5.28</td>
<td>-15.62%</td>
</tr>
<tr>
<td>Ares Management Corp</td>
<td>93.13</td>
<td>18.47</td>
<td>7.25</td>
<td>-3.78%</td>
<td>$0.56</td>
<td>$1.0</td>
<td>41.84%</td>
</tr>
<tr>
<td>T. Rowe Price Group Inc</td>
<td>11.98</td>
<td>2.36</td>
<td>3.45</td>
<td>5.82%</td>
<td>$0.65</td>
<td>$0.94</td>
<td>6.88%</td>
</tr>
<tr>
<td>Blue Owl Capital Inc</td>
<td>131.94</td>
<td>6.74</td>
<td>6.25</td>
<td>1.59%</td>
<td>$0.22</td>
<td>$0.33</td>
<td>39.85%</td>
</tr>
<tr>
<td>SEI Investments Co</td>
<td>19.12</td>
<td>4.75</td>
<td>5.23</td>
<td>6.76%</td>
<td>$0.22</td>
<td>$0.29</td>
<td>3.68%</td>
</tr>
<tr>
<td>Franklin Resources Inc</td>
<td>31.67</td>
<td>0.85</td>
<td>1.20</td>
<td>1.19%</td>
<td>$0.48</td>
<td>$1.83</td>
<td>13.08%</td>
</tr>
<tr>
<td>Janus Henderson Group PLC</td>
<td>17.51</td>
<td>1.51</td>
<td>2.82</td>
<td>2.54%</td>
<td>$0.1</td>
<td>$0.43</td>
<td>13.36%</td>
</tr>
<tr>
<td>Hamilton Lane Inc</td>
<td>30.76</td>
<td>10.71</td>
<td>13.05</td>
<td>9.38%</td>
<td>$0.08</td>
<td>$0.11</td>
<td>18.22%</td>
</tr>
<tr>
<td>Affiliated Managers Group Inc</td>
<td>11.63</td>
<td>1.59</td>
<td>3.11</td>
<td>3.72%</td>
<td>$0.26</td>
<td>$0.3</td>
<td>-1.68%</td>
</tr>
<tr>
<td>Victory Capital Holdings Inc</td>
<td>15.98</td>
<td>3.97</td>
<td>5.16</td>
<td>7.14%</td>
<td>$0.13</td>
<td>$0.17</td>
<td>7.6%</td>
</tr>
<tr>
<td>Average</td>
<td>49.28</td>
<td>5.31</td>
<td>4.85</td>
<td>3.44%</td>
<td>$1.11</td>
<td>$1.07</td>
<td>12.72%</td>
</tr>
</tbody>
</table>
<style>
 table {
 width: 100%;
 border-collapse: collapse;
 font-family: Arial, sans-serif;
 font-size: 14px;
 }

 th, td {
 padding: 8px;
 text-align: left;
 }

 th {
 background-color: #293a5a;
 color: #fff;
 text-align: left;
 }

 tr:nth-child(even) {
 background-color: #f2f4f8;
 }

 tr:hover {
 background-color: #e1e4ea;
 }

 td:nth-child(3), td:nth-child(5) {
 text-align: left;
 }

 .dividend-amount {
 font-weight: bold;
 color: #0d6efd;
 }

 .dividend-frequency {
 font-size: 12px;
 color: #6c757d;
 }
 </style>When closely examining KKR, the following trends emerge: 
<ul>
<li>
The stock's Price to Earnings ratio of 45.1 is lower than the industry average by 0.92x, suggesting potential value in the eyes of market participants.
</li>
<li>
It could be trading at a premium in relation to its book value, as indicated by its Price to Book ratio of 5.46 which exceeds the industry average by 1.03x.
</li>
<li>
The stock's relatively high Price to Sales ratio of 6.42, surpassing the industry average by 1.32x, may indicate an aspect of overvaluation in terms of sales performance.
</li>
<li>
The company has a lower Return on Equity (ROE) of 2.62%, which is 0.82% below the industry average. This indicates potential inefficiency in utilizing equity to generate profits, which could be attributed to various factors.
</li>
<li>
The company has higher Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) of $2.45 Billion, which is 2.21x above the industry average, indicating stronger profitability and robust cash flow generation.
</li>
<li>
With lower gross profit of $890 Million, which indicates 0.83x below the industry average, the company may experience lower revenue after accounting for production costs.
</li>
<li>
The company is experiencing remarkable revenue growth, with a rate of 44.56%, outperforming the industry average of 12.72%.
</li>
</ul>
<h3>Debt To Equity Ratio</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739286013_0.png" alt="debt to equity" />
The debt-to-equity (D/E) ratio is an important measure to assess the financial structure and risk profile of a company.
Considering the debt-to-equity ratio in industry comparisons allows for a concise evaluation of a company's financial health and risk profile, aiding in informed decision-making.
By considering the Debt-to-Equity ratio, KKR can be compared to its top 4 peers, leading to the following observations:
<ul>
<li>
When compared to its top 4 peers, KKR has a moderate debt-to-equity ratio of 2.1.
</li>
<li>
This implies that the company maintains a balanced financial structure with a reasonable level of debt and an appropriate reliance on equity financing.
</li>
</ul>
<h3>Key Takeaways</h3>
For KKR, the PE ratio is low compared to peers, indicating potential undervaluation. The high PB and PS ratios suggest strong market sentiment and revenue multiples. However, the low ROE implies lower profitability relative to peers. KKR's high EBITDA and revenue growth show strong operational performance, despite the low gross profit margin. Overall, KKR's valuation reflects a mix of positive market sentiment and operational efficiency within the Capital Markets industry.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Comparing KKR With Industry Competitors In Capital Markets Industry

Over the past 24 hours, Cardano's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/ada/usd">ADA</a>) price has risen 12.63% to $0.79. This continues its positive trend over the past week where it has experienced a 3.0% gain, moving from $0.77 to its current price. As it stands right now, the coin's all-time high is $3.09. 
The chart below compares the price movement and volatility for Cardano over the past 24 hours (left) to its price movement over the past week (right). The gray bands are Bollinger Bands, measuring the volatility for both the daily and weekly price movements. The wider the bands are, or the larger the gray area is at any given moment, the larger the volatility.
<img src="https://www.benzinga.com/files/images/story/2025/1739286010_0.png" alt="price_chart" />
The trading volume for the coin has tumbled 33.0% over the past week while the circulating supply of the coin has risen 0.53%. This brings the circulating supply to 35.91 billion, which makes up an estimated 79.8% of its max supply of 45.00 billion. According to our data, the current market cap ranking for ADA is #9 at $28.42 billion.
<img src="https://www.benzinga.com/files/images/story/2025/1739286010_1.png" alt="supply_and_vol" />
<a href="https://www.coingecko.com/en/api">Powered by CoinGecko API</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Movers

$ADA

Cardano Up More Than 12% In 24 hours

Records from February 10, 2025 indicate that Representative Josh Gottheimer of New Jersey made a sale of Merck &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRK#NYSE">MRK</a>), valued between $54,040 and $635,000, with the transaction dated February 10, 2025 and filed in February.
As of now, Merck &amp; Co shares are trading down 0.38% at $86.08.
Want to keep up with Josh Gottheimer and other congressional members' stock activities? Check out our <a href="https://www.benzinga.com/gov-trades/members/josh-gottheimer">government trades tool</a> for real-time updates!
<h3>Why Congressional Transactions Matter</h3>
A congressional transaction is when any representative or senator either buys or sells an individual stock.
Anyone working in Congress must file a Periodic Transaction Report to inform the public of their recent transaction within 30 days of being notified of the transaction and within 45 days of the transaction date.
In April 2012, Former President Barack Obama signed the STOCK Act into law. The act prohibits members of Congress from using private information given to them by their position for personal gain such as buying or selling a stock. The act also expanded disclosure requirements for members of Congress by requiring them to file a monthly disclosure.
<h3>Why Congressional Transactions Matter</h3>
Congressional transactions shouldn't be the primary reason for an investing decision, but they can be an important factor for an investor to consider.
When a senator or representative makes a new purchase, it could be an indication they expect the stock to rise.
A sale, on the other hand, can be made for a variety of reasons, and may not necessarily mean the seller thinks the stock will go down.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Recent Filing Shows That Rep. Josh Gottheimer Sold Over $54K Worth of Merck & Co Stock

Aureus Greenway Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGH#NASDAQ">AGH</a>) IPO will take place February, 12 on the NASDAQ exchange under the ticker AGH.
The company is offering shares at an expected price between $4.00 and $6.00 per share with an insider lock-up period of 180 days ending on August 11, 2025.
See also: <a href="https://www.benzinga.com/calendars/ipos">Benzinga IPO Calendar</a>
<h3>About Aureus Greenway Holdings Inc</h3>
Aureus Greenway Holdings Inc own and operate two public golf country clubs in Florida that each features a golf-club, consisting of over 289 acres of multi-service recreational property.
See also: <a href="https://www.benzinga.com/short-interest">Benzinga's Most Shorted Stocks</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

IPOs

Aureus Greenway Holdings Inc IPOs Tomorrow, Here's What You Need To Know

An official report on February 10, 2025 reveals Representative Byron Donalds's recent purchase of First Citizens BancShares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCNCA#NASDAQ">FCNCA</a>) stock, valued between $7,007 and $105,000. The transaction took place on February 10, 2025, as per the February filing.
At this time, First Citizens BancShares shares are trading down 0.0% at $2154.57.
<h3>Representative's Recent Trading Activity</h3>
Over the past three years, Byron Donalds executed 8 trades totaling over $8 thousand. The largest of these trades were in AppFolio and McKesson stock. Some of the key transactions the Rep. has executed recently include: None
Here is a list of Byron Donalds's most recent trades:
If you want to stay updated on Byron Donalds's trades and other congressional members, check out our <a href="https://www.benzinga.com/gov-trades/members/byron-donalds">government trades tool</a> to track their activity in real time!
<h3>Why Congressional Transactions Matter</h3>
A congressional transaction is when any representative or senator either buys or sells an individual stock.
Anyone working in Congress must file a Periodic Transaction Report to inform the public of their recent transaction within 30 days of being notified of the transaction and within 45 days of the transaction date.
In April 2012, Former President Barack Obama signed the STOCK Act into law. The act prohibits members of Congress from using private information given to them by their position for personal gain such as buying or selling a stock. The act also expanded disclosure requirements for members of Congress by requiring them to file a monthly disclosure.
<h3>Why Congressional Transactions Matter</h3>
Congressional transactions shouldn't be the primary reason for an investing decision, but they can be an important factor for an investor to consider.
When a senator or representative makes a new purchase, it could be an indication they expect the stock to rise.
A sale, on the other hand, can be made for a variety of reasons, and may not necessarily mean the seller thinks the stock will go down.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

FCNCA

Florida Rep. Byron Donalds Bought Over $7K Worth of First Citizens BancShares Stock: Here's What You Should Know

Cantor Fitzgerald analyst Josh Schimmer reiterates Septerna (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEPN#NASDAQ">SEPN</a>) with a Overweight and maintains $50 price target.

Price Target

Reiteration

Analyst Ratings

SEPN

Cantor Fitzgerald Reiterates Overweight on Septerna, Maintains $50 Price Target

WIIM

ACGL

Arch Capital Group shares are trading lower. The company reported Q4 financial results.

Ecolab Inc&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ECL#NYSE">ECL</a>) shares are trading higher after the company reported&nbsp;fourth-quarter sales growth of&nbsp;2% year-on-year to&nbsp;$4.005 billion,&nbsp;beating the&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/b43620814/ecolab-delivers-strong-fourth-quarter-and-record-2024-performance-reported-diluted-eps-1-66-adjust" rel="noreferrer noopener">consensus estimate of&nbsp;$3.99 billion</a>.
Organic sales grew&nbsp;4%, led by strong growth in the Industrial and Healthcare &amp; Life Sciences segments and the Pest Elimination and Institutional &amp; Specialty segments.
In fixed currency, Global Industrial sales grew&nbsp;4% to&nbsp;$2.067 billion, Global Institutional &amp; Specialty climbed&nbsp;6% to&nbsp;$1.367 billion, Global Healthcare &amp; Life Sciences fell&nbsp;23% to&nbsp;$322.1 million and Global Pest Elimination increased&nbsp;8% to&nbsp;$295.2 million.
Selling, general and administrative expenses rose 1% to $1.1 billion. Adjusted operating income for the quarter increased 10% to $688.2 million, with an adjusted operating margin of 17.3% vs. 15.9% a year ago.
Adjusted EPS of&nbsp;$1.81 (+17% Y/Y) <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">beat the analyst consensus estimate of&nbsp;$1.79</a>.
The company held&nbsp;$1.26 billion in cash and equivalents as of December end.
Outlook: Ecolab expects first-quarter adjusted EPS of $1.47 &#8211; $1.53, vs. the $1.48 estimate, and 2025 adjusted EPS of $7.42 &#8211; $7.62, <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">compared to the $7.40 estimate</a>.
Christophe Beck, Ecolab&#8217;s chairman and chief executive officer, said,
&#8220;We enter 2025 confident in our ability to deliver continued strong performance in a dynamic environment. Growth in the United States, our largest and most profitable region, continues to be very strong, and growth across the rest of the world is solid as we more than offset uneven macroeconomic trends.&#8221;
&#8220;Additionally, we will implement value pricing that reflects the increasing value Ecolab delivers to customers. As a result, we expect to deliver attractive organic operating income margin expansion, as our confidence in reaching our 20% margin target over the next three years continues to strengthen.&#8221;
Investors can gain exposure to the stock via&nbsp;VanEck Environmental Services ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVX#NYSE">EVX</a>) and&nbsp;Invesco Water Resources ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHO#NASDAQ">PHO</a>)
Price Action: ECL shares are up 6.76% at $262.57 at the last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/43622400" target="_blank" rel="noreferrer noopener">Sam Altman Says Elon Musk&#8217;s $97B Bid For OpenAI Is A Move To &#8216;Slow Down A Competitor&#8217;</a></li>
</ul>

Earnings

Equities

Large Cap

Guidance

Ecolab Q4: Solid EPS Growth, Industrial And Institutional Acceleration, 2025 Momentum And More

Vertex Pharmaceuticals Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>) reported mixed results for its fourth <a href="https://www.benzinga.com/quote/VRTX/earnings">quarter on Monday</a>.
The company posted quarterly adjusted earnings of $3.48 per share which missed the analyst consensus estimate of $4.03 per share. The company reported quarterly sales of $2.912 billion which beat the analyst consensus estimate of $2.781 billion.
&#8220;2024 marked a year of tremendous growth for Vertex and we anticipate 2025 will be another important year with the landmark JOURNAVX approval and launch for moderate-to-severe acute pain; the launch of our fifth CF medicine, ALYFTREK; the continuing global launch of CASGEVY; and multiple ongoing pivotal trials. We are excited to drive diversification of the revenue base, disease areas of focus, R&amp;D pipeline, and geographies to continue to deliver long-term value to both patients and shareholders,&#8221; said Reshma Kewalramani, M.D., Chief Executive Officer and President of Vertex.
Vertex Pharmaceuticals said it sees FY25 revenue of $11.75 billion to $12.00 billion, versus market estimates of $11.84 billion.
Vertex Pharmaceuticals shares fell 2.5% to trade at $458.15 on Tuesday.
These analysts made changes to their price targets on Vertex Pharmaceuticals following earnings announcement.
<ul>
<li>Morgan Stanley analyst Matthew Harrison maintained Vertex Pharmaceuticals with an Equal-Weight and raised the price target from $450 to $459.</li>
<li>Barclays analyst Gena Wang maintained the stock with an Equal-Weight and raised the price target from $435 to $46.</li>
<li>HC Wainwright &amp; Co. analyst Andrew Fein, meanwhile, reiterated Vertex Pharmaceuticals with a Buy and maintained a $550 price target.</li>
</ul>
Considering buying VRTX stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="625" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/11095438/image-97-1024x625.png" alt="" class="wp-image-776741" style="width:592px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/11095438/image-97-1024x625.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/11095438/image-97-300x183.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/11095438/image-97-768x468.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/11095438/image-97.png 1092w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43592071/top-3-tech-stocks-that-may-jump-this-month">Top 3 Tech Stocks That May Jump This Month</a></li>
</ul>

VRTX

Vertex Pharmaceuticals Analysts Increase Their Forecasts After Q4 Results

Scotiabank analyst Greg Harrison maintains Vertex Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>) with a Sector Perform and raises the price target from $433 to $450.

Scotiabank Maintains Sector Perform on Vertex Pharmaceuticals, Raises Price Target to $450

Cantor Fitzgerald analyst Olivia Brayer reiterates Vertex Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>) with a Overweight and maintains $480 price target.

Cantor Fitzgerald Reiterates Overweight on Vertex Pharmaceuticals, Maintains $480 Price Target

Scotiabank analyst Allan Verkhovski maintains Monday.Com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDY#NASDAQ">MNDY</a>) with a Sector Outperform and raises the price target from $300 to $400.

MNDY

Scotiabank Maintains Sector Outperform on Monday.Com, Raises Price Target to $400

<a href="https://event.webcasts.com/starthere.jsp?ei=1705636&amp;tp_key=ba14762bab&amp;tp_special=8" title="https://event.webcasts.com/starthere.jsp?ei=1705636&amp;tp_key=ba14762bab&amp;tp_special=8">https://event.webcasts.com/starthere.jsp?ei=1705636&amp;tp_key=ba14762bab&amp;tp_special=8</a>

JPMorgan CFO Says Board Is Thinking About Succession Planning With Fairness And Focus As Ever

Scotiabank analyst George Farmer maintains INmune Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INMB#NASDAQ">INMB</a>) with a Sector Outperform and raises the price target from $22 to $23.

INMB

Scotiabank Maintains Sector Outperform on INmune Bio, Raises Price Target to $23

CARR

Carrier Global shares are trading lower after the company reported worse-than-expected Q4 sales results.

Edgewell Personal Care Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPC#NYSE">EPC</a>) reported downbeat financial results for the <a href="https://www.benzinga.com/quote/EPC/earnings">first quarter on Monday</a>.
Edgewell Personal Care reported quarterly adjusted earnings of 7 cents per share which missed the analyst consensus estimate of 12 cents per share. The company reported quarterly sales of $478.40 million which missed the analyst consensus estimate of $480.07 million.
Edgewell Personal Care said it sees FY25 adjusted EPS of $3.15 to $3.35, versus estimates of $3.18.
Edgewell Personal Care shares gained 2.5% to trade at $29.33 on Tuesday.
These analysts made changes to their price targets on Edgewell Personal Care following earnings announcement.
<ul>
<li>Morgan Stanley analyst Dara Mohsenian maintained Edgewell Personal Care with an Underweight and lowered the price target from $35 to $32.</li>
<li>Wells Fargo analyst Chris Carey maintained the stock with an Overweight and lowered the price target from $37 to $35.</li>
<li>RBC Capital analyst Nik Modi maintained Edgewell Personal Care with an Outperform and lowered the price target from $48 to $43.</li>
<li>Barclays analyst Lauren Lieberman maintained the stock with an Equal-Weight and lowered the price target from $33 to $30.</li>
</ul>
Considering buying EPC stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="619" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/11094659/image-96-1024x619.png" alt="" class="wp-image-776722" style="width:707px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/11094659/image-96-1024x619.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/11094659/image-96-300x181.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/11094659/image-96-768x464.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/11094659/image-96.png 1096w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43592071/top-3-tech-stocks-that-may-jump-this-month">Top 3 Tech Stocks That May Jump This Month</a></li>
</ul>

Edgewell Personal Care Analysts Cut Their Forecasts After Weak Earnings

Cantor Fitzgerald analyst Yi Fu Lee initiates coverage on Domo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOMO#NASDAQ">DOMO</a>) with a Overweight rating and announces Price Target of $11.

Comments

Longfor Gr Hldgs

空売り

Longfor Gr Hldgs (OTC:LGFRY) 株価情報, 空売り情報

ニュース

パートナーシップ

ベンジンガ・グローバル